The Scheme is expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector.
It will be part of the umbrella scheme for the Development of the Pharmaceutical Industry.
Objective: (1)To enhance India’s manufacturing capabilities by increasing investment; (2) Product diversification to include high-value goods.
Target Groups: The manufacturers who are registered in India will be grouped based on their Global Manufacturing Revenue (GMR) to ensure wider applicability of the scheme
Quantum of Incentive: 15,000 crores.
Category of Goods covered:
Category 1: Biopharmaceuticals; Complex generic drugs; Patented drugs or drugs nearing patent expiry; Cell-based or gene therapy drugs; Orphan drugs; Other drugs as approved.
Category 2: Active Pharmaceutical Ingredients, Key Starting Materials, Drug Intermediates.
Category 3: Drugs not covered under Category 1 and 2.
